1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Spinal Non-Fusion - Pipeline Review, 2015

Spinal Non-Fusion - Pipeline Review, 2015

  • September 2015
  • -
  • GlobalData
  • -
  • 229 pages

Spinal Non-Fusion - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Spinal Non-Fusion - Pipeline Review, 2015" provides an overview of Spinal Non-Fusion devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Non-Fusion pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Spinal Non-Fusion devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Spinal Non-Fusion devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Spinal Non-Fusion devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Spinal Non-Fusion - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 14
2 Introduction 15
2.1 Spinal Non-Fusion Overview 15
3 Products under Development 16
3.1 Spinal Non-Fusion - Pipeline Products by Stage of Development 16
3.2 Spinal Non-Fusion - Pipeline Products by Segment 17
3.3 Spinal Non-Fusion - Pipeline Products by Territory 18
3.4 Spinal Non-Fusion - Pipeline Products by Regulatory Path 19
3.5 Spinal Non-Fusion - Pipeline Products by Estimated Approval Date 20
3.6 Spinal Non-Fusion - Ongoing Clinical Trials 21
4 Spinal Non-Fusion - Pipeline Products under Development by Companies 22
4.1 Spinal Non-Fusion Companies - Pipeline Products by Stage of Development 22
4.2 Spinal Non-Fusion - Pipeline Products by Stage of Development 25
5 Spinal Non-Fusion Companies and Product Overview 28
5.1 ALCeraX Medizintechnik GmbH Company Overview 28
5.1.1 ALCeraX Medizintechnik GmbH Pipeline Products and Ongoing Clinical Trials Overview 28
5.2 Alphatec Holdings, Inc. Company Overview 29
5.2.1 Alphatec Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
5.3 Amedica Corporation Company Overview 32
5.3.1 Amedica Corporation Pipeline Products and Ongoing Clinical Trials Overview 32
5.4 Apollo Implants LLC Company Overview 35
5.4.1 Apollo Implants LLC Pipeline Products and Ongoing Clinical Trials Overview 35
5.5 ARO Medical, LLC Company Overview 36
5.5.1 ARO Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 36
5.6 Arthro Kinetics AG Company Overview 37
5.6.1 Arthro Kinetics AG Pipeline Products and Ongoing Clinical Trials Overview 37
5.7 Artimplant AB Company Overview 38
5.7.1 Artimplant AB Pipeline Products and Ongoing Clinical Trials Overview 38
5.8 Ascendx Spine, Inc. Company Overview 42
5.8.1 Ascendx Spine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.9 AxioMed Spine Corporation Company Overview 43
5.9.1 AxioMed Spine Corporation Pipeline Products and Ongoing Clinical Trials Overview 43
5.10 Baxano Surgical Inc Company Overview 48
5.10.1 Baxano Surgical Inc Pipeline Products and Ongoing Clinical Trials Overview 48
5.11 Chi2Gel Ltd. Company Overview 52
5.11.1 Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 52
5.12 City University London Company Overview 53
5.12.1 City University London Pipeline Products and Ongoing Clinical Trials Overview 53
5.13 Covexus Medical Technologies, LLC Company Overview 54
5.13.1 Covexus Medical Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 54
5.14 Crocker Spinal Technologies, Inc. Company Overview 55
5.14.1 Crocker Spinal Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
5.15 CryoLife, Inc. Company Overview 57
5.15.1 CryoLife, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
5.16 Curtin University Company Overview 59
5.16.1 Curtin University Pipeline Products and Ongoing Clinical Trials Overview 59
5.17 DePuy Companies Company Overview 60
5.17.1 DePuy Companies Pipeline Products and Ongoing Clinical Trials Overview 60
5.18 Disc Motion Technologies Company Overview 64
5.18.1 Disc Motion Technologies Pipeline Products and Ongoing Clinical Trials Overview 64
5.19 Elite Surgical Supplies (Pty) Limited Company Overview 68
5.19.1 Elite Surgical Supplies (Pty) Limited Pipeline Products and Ongoing Clinical Trials Overview 68
5.20 FlexSIS Ltd. Company Overview 69
5.20.1 FlexSIS Ltd. Pipeline Products and Ongoing Clinical Trials Overview 69
5.21 Flexuspine, Inc. Company Overview 70
5.21.1 Flexuspine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
5.22 Gentis Inc. Company Overview 71
5.22.1 Gentis Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
5.23 Globus Medical, Inc. Company Overview 74
5.23.1 Globus Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
5.24 Hydrospine, Inc. Company Overview 81
5.24.1 Hydrospine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 81
5.25 IB Medical AB Company Overview 82
5.25.1 IB Medical AB Pipeline Products and Ongoing Clinical Trials Overview 82
5.26 Innovia LLC Company Overview 83
5.26.1 Innovia LLC Pipeline Products and Ongoing Clinical Trials Overview 83
5.27 Integra LifeSciences Holdings Corporation Company Overview 84
5.27.1 Integra LifeSciences Holdings Corporation Pipeline Products and Ongoing Clinical Trials Overview 84
5.28 Jemo Spine, LLC. Company Overview 86
5.28.1 Jemo Spine, LLC. Pipeline Products and Ongoing Clinical Trials Overview 86
5.29 LDR Holding Corporation Company Overview 87
5.29.1 LDR Holding Corporation Pipeline Products and Ongoing Clinical Trials Overview 87
5.30 Medical University of South Carolina Company Overview 89
5.30.1 Medical University of South Carolina Pipeline Products and Ongoing Clinical Trials Overview 89
5.31 Medicrea International SA Company Overview 90
5.31.1 Medicrea International SA Pipeline Products and Ongoing Clinical Trials Overview 90
5.32 Medtronic plc Company Overview 95
5.32.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 95
5.33 MI4 Spine, LLC Company Overview 100
5.33.1 MI4 Spine, LLC Pipeline Products and Ongoing Clinical Trials Overview 100
5.34 MicroPort Scientific Corporation Company Overview 101
5.34.1 MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 101
5.35 MiMedx Group, Inc Company Overview 103
5.35.1 MiMedx Group, Inc Pipeline Products and Ongoing Clinical Trials Overview 103
5.36 Nano Interface Technology, Inc. Company Overview 105
5.36.1 Nano Interface Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 105
5.37 NeuroPro Technologies, Inc. Company Overview 106
5.37.1 NeuroPro Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 106
5.38 Nexgen Spine Inc. Company Overview 107
5.38.1 Nexgen Spine Inc. Pipeline Products and Ongoing Clinical Trials Overview 107
5.39 NLT Spine Company Overview 109
5.39.1 NLT Spine Pipeline Products and Ongoing Clinical Trials Overview 109
5.40 NuVasive, Inc. Company Overview 113
5.40.1 NuVasive, Inc. Pipeline Products and Ongoing Clinical Trials Overview 113
5.41 Orthonex LLC Company Overview 119
5.41.1 Orthonex LLC Pipeline Products and Ongoing Clinical Trials Overview 119
5.42 Paramount Surgicals Company Overview 122
5.42.1 Paramount Surgicals Pipeline Products and Ongoing Clinical Trials Overview 122
5.43 Precision Spine, Inc. Company Overview 125
5.43.1 Precision Spine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 125
5.44 Premia Spine, Ltd. Company Overview 126
5.44.1 Premia Spine, Ltd. Pipeline Products and Ongoing Clinical Trials Overview 126
5.45 Ranier Technology Limited Company Overview 129
5.45.1 Ranier Technology Limited Pipeline Products and Ongoing Clinical Trials Overview 129
5.46 Raymedica, LLC Company Overview 132
5.46.1 Raymedica, LLC Pipeline Products and Ongoing Clinical Trials Overview 132
5.47 RE Spine, LLC Company Overview 134
5.47.1 RE Spine, LLC Pipeline Products and Ongoing Clinical Trials Overview 134
5.48 Reduction Technologies, Inc. Company Overview 135
5.48.1 Reduction Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 135
5.49 Replication Medical, Inc. Company Overview 136
5.49.1 Replication Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 136
5.50 Resoimplant GmbH (Inactive) Company Overview 137
5.50.1 Resoimplant GmbH (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 137
5.51 S14 Implants Company Overview 138
5.51.1 S14 Implants Pipeline Products and Ongoing Clinical Trials Overview 138
5.52 SeaSpine, Inc. (Inactive) Company Overview 139
5.52.1 SeaSpine, Inc. (Inactive) Pipeline Products and Ongoing Clinical Trials Overview 139
5.53 Simpirica Spine, Inc. Company Overview 140
5.53.1 Simpirica Spine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 140
5.54 Simplify Medical, Inc. Company Overview 142
5.54.1 Simplify Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 142
5.55 Smart Disc, Inc. Company Overview 143
5.55.1 Smart Disc, Inc. Pipeline Products and Ongoing Clinical Trials Overview 143
5.56 Spinal Kinetics Inc. Company Overview 144
5.56.1 Spinal Kinetics Inc. Pipeline Products and Ongoing Clinical Trials Overview 144
5.57 Spinalcyte Llc Company Overview 149
5.57.1 Spinalcyte Llc Pipeline Products and Ongoing Clinical Trials Overview 149
5.58 SpinalMotion, Inc. Company Overview 150
5.58.1 SpinalMotion, Inc. Pipeline Products and Ongoing Clinical Trials Overview 150
5.59 SpinalVu Inc Company Overview 157
5.59.1 SpinalVu Inc Pipeline Products and Ongoing Clinical Trials Overview 157
5.60 Spine Smith, LP Company Overview 158
5.60.1 Spine Smith, LP Pipeline Products and Ongoing Clinical Trials Overview 158
5.61 Spine Wave, Inc. Company Overview 160
5.61.1 Spine Wave, Inc. Pipeline Products and Ongoing Clinical Trials Overview 160
5.62 Spine21 Ltd. Company Overview 163
5.62.1 Spine21 Ltd. Pipeline Products and Ongoing Clinical Trials Overview 163
5.63 SpineLab AG Company Overview 164
5.63.1 SpineLab AG Pipeline Products and Ongoing Clinical Trials Overview 164
5.64 Stryker Corporation Company Overview 165
5.64.1 Stryker Corporation Pipeline Products and Ongoing Clinical Trials Overview 165
5.65 Synergy Disc Replacement, Inc. Company Overview 167
5.65.1 Synergy Disc Replacement, Inc. Pipeline Products and Ongoing Clinical Trials Overview 167
5.66 Synthes, Inc. Company Overview 169
5.66.1 Synthes, Inc. Pipeline Products and Ongoing Clinical Trials Overview 169
5.67 Takiron Co., Ltd. Company Overview 170
5.67.1 Takiron Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 170
5.68 TrueMotion Spine, Inc. Company Overview 172
5.68.1 TrueMotion Spine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 172
5.69 University of Colorado Company Overview 174
5.69.1 University of Colorado Pipeline Products and Ongoing Clinical Trials Overview 174
5.70 University of South Florida Company Overview 175
5.70.1 University of South Florida Pipeline Products and Ongoing Clinical Trials Overview 175
5.71 Vertebral Technologies, Inc. Company Overview 176
5.71.1 Vertebral Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 176
5.72 Weill Cornell Medical College Company Overview 180
5.72.1 Weill Cornell Medical College Pipeline Products and Ongoing Clinical Trials Overview 180
5.73 X-spine Systems, Inc. Company Overview 181
5.73.1 X-spine Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 181
5.74 Zimmer Biomet Holdings, Inc. Company Overview 182
5.74.1 Zimmer Biomet Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 182
6 Spinal Non-Fusion - Recent Developments 188
7 Appendix 226
7.1 Methodology 226
7.2 About GlobalData 228
7.3 Contact Us 229
7.4 Disclaimer 229

1.1 List of Tables
Table 1: Spinal Non-Fusion - Pipeline Products by Stage of Development 16
Table 2: Spinal Non-Fusion - Pipeline Products by Segment 17
Table 3: Spinal Non-Fusion - Pipeline Products by Territory 18
Table 4: Spinal Non-Fusion - Pipeline Products by Regulatory Path 19
Table 5: Spinal Non-Fusion - Pipeline Products by Estimated Approval Date 20
Table 6: Spinal Non-Fusion - Ongoing Clinical Trials 21
Table 7: Spinal Non-Fusion Companies - Pipeline Products by Stage of Development 22
Table 8: Spinal Non-Fusion - Pipeline Products by Stage of Development 25
Table 9: ALCeraX Medizintechnik GmbH Pipeline Products and Ongoing Clinical Trials Overview 28
Table 10: ConCera - Product Status 28
Table 11: ConCera - Product Description 28
Table 12: Alphatec Holdings, Inc. Pipeline Products and Ongoing Clinical Trials Overview 29
Table 13: TECORP Telescopic Corpectomy System - Product Status 30
Table 14: TECORP Telescopic Corpectomy System - Product Description 30
Table 15: TeCorp-C Telescopic Corpectomy System - Product Status 31
Table 16: TeCorp-C Telescopic Corpectomy System - Product Description 31
Table 17: Amedica Corporation Pipeline Products and Ongoing Clinical Trials Overview 32
Table 18: Altia TDR-C - Product Status 33
Table 19: Altia TDR-C - Product Description 33
Table 20: Spartacus - Product Status 34
Table 21: Spartacus - Product Description 34
Table 22: Apollo Implants LLC Pipeline Products and Ongoing Clinical Trials Overview 35
Table 23: Spinal Implant - Product Status 35
Table 24: Spinal Implant - Product Description 35
Table 25: ARO Medical, LLC Pipeline Products and Ongoing Clinical Trials Overview 36
Table 26: ARO Cinch - Product Status 36
Table 27: ARO Cinch - Product Description 36
Table 28: Arthro Kinetics AG Pipeline Products and Ongoing Clinical Trials Overview 37
Table 29: NuReS - Product Status 37
Table 30: NuReS - Product Description 37
Table 31: Artimplant AB Pipeline Products and Ongoing Clinical Trials Overview 38
Table 32: Artelon Facet Spacer - Product Status 39
Table 33: Artelon Facet Spacer - Product Description 39
Table 34: Artimplant AB - Ongoing Clinical Trials Overview 40
Table 35: Artelon Facet Spacer - To Evaluate The Feasibility Of Treating Painful Osteoarthritis Of The Lumbar Facet Joints Of The Spine With Artelon Implant 41
Table 36: Ascendx Spine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 37: Motion Preserving Cervical Dynamic Stabilization Plate - Product Status 42
Table 38: Motion Preserving Cervical Dynamic Stabilization Plate - Product Description 42
Table 39: AxioMed Spine Corporation Pipeline Products and Ongoing Clinical Trials Overview 43
Table 40: Freedom Cervical Disc - Product Status 43
Table 41: Freedom Cervical Disc - Product Description 43
Table 42: Freedom Lumbar Disc - Product Status 44
Table 43: Freedom Lumbar Disc - Product Description 44
Table 44: AxioMed Spine Corporation - Ongoing Clinical Trials Overview 45
Table 45: Freedom Lumbar Disc - An IDE Study of the Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease 46
Table 46: Freedom Lumbar Disc - Pivotal Clinical Study Of The Freedom Lumbar Disc 46
Table 47: Freedom Cervical Disc - Freedom Cervical Disc Use in the Treatment of Cervical Degenerative Disc Disease 47
Table 48: Baxano Surgical Inc Pipeline Products and Ongoing Clinical Trials Overview 48
Table 49: Percutaneous Nucleus Replacement - Product Status 48
Table 50: Percutaneous Nucleus Replacement - Product Description 49
Table 51: TranS1 - Percutaneous Disc Replacement (PDR) - Product Status 49
Table 52: TranS1 - Percutaneous Disc Replacement (PDR) - Product Description 49
Table 53: Baxano Surgical Inc - Ongoing Clinical Trials Overview 50
Table 54: Percutaneous Nucleus Replacement - Feasibility Study To Assess The Safety And Effectiveness Of The PNR 51
Table 55: Chi2Gel Ltd. Pipeline Products and Ongoing Clinical Trials Overview 52
Table 56: Chi2Disc - Product Status 52
Table 57: Chi2Disc - Product Description 52
Table 58: City University London Pipeline Products and Ongoing Clinical Trials Overview 53
Table 59: Artificial Intervertebral Disc Prosthesis - Product Status 53
Table 60: Artificial Intervertebral Disc Prosthesis - Product Description 53
Table 61: Covexus Medical Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 54
Table 62: Spheritas - Product Status 54
Table 63: Spheritas - Product Description 54
Table 64: Crocker Spinal Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 55
Table 65: FlexBac - Product Status 55
Table 66: FlexBac - Product Description 55
Table 67: FlexSure - Product Status 56
Table 68: FlexSure - Product Description 56
Table 69: CryoLife, Inc. Pipeline Products and Ongoing Clinical Trials Overview 57
Table 70: Biodisc Nucleus Pulposus Replacement - Product Status 58
Table 71: Biodisc Nucleus Pulposus Replacement - Product Description 58
Table 72: Curtin University Pipeline Products and Ongoing Clinical Trials Overview 59
Table 73: SZ Device - Product Status 59
Table 74: SZ Device - Product Description 59
Table 75: DePuy Companies Pipeline Products and Ongoing Clinical Trials Overview 60
Table 76: DISCOVER Artificial Cervical Disc - Product Status 61
Table 77: DISCOVER Artificial Cervical Disc - Product Description 61
Table 78: DePuy Companies - Ongoing Clinical Trials Overview 62
Table 79: DISCOVER Artificial Cervical Disc - A Multi-center, Prospective, Randomized Controlled Trial Comparing Cervical Arthroplasty to Anterior Cervical Discectomy and Fusion for the Treatment of Cervical Degenerative Disc Disease 63
Table 80: DISCOVER Artificial Cervical Disc - Treatment of Cervical Radiculopathy with Arthroplasty Compared with Discectomy with Fusion And Cage (ACDF). Clinical, Radiological And Biomechanical Aspects. A Randomized Multi-center Study 63
Table 81: Disc Motion Technologies Pipeline Products and Ongoing Clinical Trials Overview 64
Table 82: Inlign ARC - Product Status 65
Table 83: Inlign ARC - Product Description 65
Table 84: Inlign PL - Product Status 66
Table 85: Inlign PL - Product Description 66
Table 86: Inlign TMS - Product Status 67
Table 87: Inlign TMS - Product Description 67
Table 88: Elite Surgical Supplies (Pty) Limited Pipeline Products and Ongoing Clinical Trials Overview 68
Table 89: BioLign Cervical Disc - Product Status 68
Table 90: BioLign Cervical Disc - Product Description 68
Table 91: FlexSIS Ltd. Pipeline Products and Ongoing Clinical Trials Overview 69
Table 92: Spine Stabilization System - Product Status 69
Table 93: Spine Stabilization System - Product Description 69
Table 94: Flexuspine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 95: Flexuspine Functional Spinal Unit - Product Status 70
Table 96: Flexuspine Functional Spinal Unit - Product Description 70
Table 97: Gentis Inc. Pipeline Products and Ongoing Clinical Trials Overview 71
Table 98: DiscCell - Product Status 71
Table 99: DiscCell - Product Description 71
Table 100: Gentis Inc. - Ongoing Clinical Trials Overview 72
Table 101: DiscCell - Pivotal Clinical Study Of DiscCell Augmentation Versus Microdiscectomy 73
Table 102: Globus Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 74
Table 103: FLEXUS Interspinous Spacer - Product Status 75
Table 104: FLEXUS Interspinous Spacer - Product Description 75
Table 105: Total Facet Arthroplasty System - Product Status 76
Table 106: Total Facet Arthroplasty System - Product Description 76
Table 107: Triumph Lumbar Disc - Product Status 77
Table 108: Triumph Lumbar Disc - Product Description 77
Table 109: Globus Medical, Inc. - Ongoing Clinical Trials Overview 78
Table 110: Total Facet Arthroplasty System - Archus Orthopedics Completes Worlds First Lumbosacral Facet Joint Replacement 79
Table 111: Triumph Lumbar Disc - A Prospective Clinical Investigation of The TRIUMPH Lumbar Disc: A Pilot Study 80
Table 112: Hydrospine, Inc. Pipeline Products and Ongoing Clinical Trials Overview 81
Table 113: Intervertebral Disc Repair System - Product Status 81
Table 114: Intervertebral Disc Repair System - Product Description 81
Table 115: IB Medical AB Pipeline Products and Ongoing Clinical Trials Overview 82
Table 116: Static Compression Device - Product Status 82
Table 117: Static Compression Device - Product Description 82
Table 118: Innovia LLC Pipeline Products and Ongoing Clinical Trials Overview 83
Table 119: Interspinous Spacer - Product Status 83
Table 120: Interspinous Spacer - Product Description 83
Table 121: Integra LifeSciences Holdings Corporation Pipeline Products and Ongoing Clinical Trials Overview 84
Table 122: eDISC - Product Status 85
Table 123: eDISC - Product Description 85
Table 124: Jemo Spine, LLC. Pipeline Products and Ongoing Clinical Trials Overview 86
Table 125: Omega Dynamic Decompression and Stabilization System - Product Status 86
Table 126: Omega Dynamic Decompression and Stabilization System - Product Description 86
Table 127: LDR Holding Corporation Pipeline Products and Ongoing Clinical Trials Overview 87
Table 128: Mobi-L - Product Status 88
Table 129: Mobi-L - Product Description 88
Table 130: Medical University of South Carolina Pipeline Products and Ongoing Clinical Trials Overview 89
Table 131: Artificial Intervertebral Disc - Product Status 89
Table 132: Artificial Intervertebral Disc - Product Description 89
Table 133: Medicrea International SA Pipeline Products and Ongoing Clinical Trials Overview 90
Table 134: Granvia-C - Product Status 91
Table 135: Granvia-C - Product Description 91
Table 136: LaminoJAWS - Product Status 92
Table 137: LaminoJAWS - Product Description 92
Table 138: Medicrea International SA - Ongoing Clinical Trials Overview 93
Table 139: Granvia-C - The GRANVIA-C Cervical Disc Prosthesis to Treat Symptomatic Degenerative Disc Diseases 94
Table 140: Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 95
Table 141: DIAM Spinal Stabilization System - Product Status 96
Table 142: DIAM Spinal Stabilization System - Product Description 96
Table 143: Maverick Artificial Lumbar Disc - Product Status 97
Table 144: Maverick Artificial Lumbar Disc - Product Description 97
Table 145: Medtronic plc - Ongoing Clinical Trials Overview 98
Table 146: DIAM Spinal Stabilization System - A Prospective, Randomized, Controlled Pivotal Clinical Investigation of DIAM Spinal Stabilization System in Patients With Lumbar Degenerative Disc Disease 99
Table 147: MI4 Spine, LLC Pipeline Products and Ongoing Clinical Trials Overview 100
Table 148: Next Generation Dynamic System - Product Status 100
Table 149: Next Generation Dynamic System - Product Description 100
Table 150: MicroPort Scientific Corporation Pipeline Products and Ongoing Clinical Trials Overview 101
Table 151: Spinal Dynamic Stabilization System - Product Status 102
Table 152: Spinal Dynamic Stabilization System - Product Description 102
Table 153: MiMedx Group, Inc Pipeline Products and Ongoing Clinical Trials Overview 103
Table 154: SaluDisc - Product Status 104
Table 155: SaluDisc - Product Description 104
Table 156: Nano Interface Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 105
Table 157: Spinal Disc - Product Status 105
Table 158: Spinal Disc - Product Description 105
Table 159: NeuroPro Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 106
Table 160: Percutaneous Dynamic Stabilization - Product Status 106
Table 161: Percutaneous Dynamic Stabilization - Product Description 106
Table 162: Nexgen Spine Inc. Pipeline Products and Ongoing Clinical Trials Overview 107
Table 163: Physio-C - Product Status 107
Table 164: Physio-C - Product Description 107

1.2 List of Figures
Figure 1: Spinal Non-Fusion - Pipeline Products by Stage of Development 16
Figure 2: Spinal Non-Fusion - Pipeline Products by Segment 17
Figure 3: Spinal Non-Fusion - Pipeline Products by Territory 18
Figure 4: Spinal Non-Fusion - Pipeline Products by Regulatory Path 19
Figure 5: Spinal Non-Fusion - Pipeline Products by Estimated Approval Date 20
Figure 6: Spinal Non-Fusion - Ongoing Clinical Trials 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline ...

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2016

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, ...

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Intercellular Adhesion Molecule 1 (Major Group Rhinovirus ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.